MRI/US Fusion Prostate Biopsy - Mitchell Humphreys

E. David Crawford is joined by Dr. Mitchell R. Humphreys to discuss the role of MRI and fusion biopsies in detection of prostate cancer. One of the key advantages of this technology is being able to find high grades level of cancer, that may go undetected, resulting in the ability to better manage high risk prostate cancer leading to improvements for patients overall.


Mitchell R. Humphreys, MD
Professor of Urology
Associate Dean CPD
Endourology Fellowship Director

Dr. Humphreys has been involved with many areas of clinical and outcomes based research. His three main areas of research interest are currently:

  • Urologic malignancy and innovative minimally invasive surgical procedures and technology to improve treatments and outcomes
  • Nephrolithiais basic sciences to look at stone risk modifiers and methods of influencing stone disease
  • Benign prostatic hyperplasia (BPH) and associated genetic markers that can predict surgical outcomes, or provide molecular targets for future intervention as well as clinical outcome initiatives to maximize quality of life and functional results with novel laser treatments.
E. David Crawford, MD